YorkBridge Wealth Partners’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

YorkBridge Wealth Partners’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-110	Closed	-$1K	–	741
2019 Q2	$1K	Hold	110	–	–	﹤0.01%	744
2019 Q1	$3K	Hold	110	–	–	﹤0.01%	687
2018 Q4	$2K	Hold	110	–	–	﹤0.01%	699
2018 Q3	$6K	Hold	110	–	–	﹤0.01%	647
2018 Q2	$8K	Hold	110	–	–	﹤0.01%	644
2018 Q1	$7K	Hold	110	–	–	﹤0.01%	661
2017 Q4	$11K	Hold	110	–	–	0.01%	625
2017 Q3	$15K	Hold	110	–	–	0.01%	593
2017 Q2	$16K	Hold	110	–	–	0.01%	568
2017 Q1	$17K	Buy	+110	New	+$12.3K	0.01%	546

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

YorkBridge Wealth Partners's TTPH Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 110 shares — an estimated $1K sold.

YorkBridge Wealth Partners first reported a position in TTPH in Q1 2017 and held it in 10 quarters. The position peaked at $17K in Q1 2017. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

YorkBridge Wealth Partners reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
YorkBridge Wealth Partners sold 110 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $1K.
YorkBridge Wealth Partners first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2017 and held it in 10 quarters.
YorkBridge Wealth Partners's Tetraphase Pharmaceuticals, Inc. position peaked at $17K in Q1 2017.
26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.